|
1
|
Hidalgo M: Pancreatic cancer. N Engl J
Med. 362:1605–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yadav D and Lowenfels AB: The epidemiology
of pancreatitis and pancreatic cancer. Gastroenterology.
144:1252–1261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ryan DP, Hong TS and Bardeesy N:
Pancreatic adenocarcinoma. N Engl J Med. 371:1039–1049. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peto R, Lopez AD, Pan H and Thun MJ: World
Cancer Report. 2014.
|
|
6
|
Mohammed S, Van Buren G 2nd and Fisher WE:
Pancreatic cancer: advances in treatment. World J Gastroenterol.
20:9354–9360. 2014.PubMed/NCBI
|
|
7
|
Dunne RF and Hezel AF: Genetics and
Biology of Pancreatic Ductal Adenocarcinoma. Hematol Oncol Clin
North Am. 29:595–608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamazaki K, Masugi Y, Effendi K, Tsujikawa
H, Hiraoka N, Kitago M, Shinoda M, Itano O, Tanabe M, Kitagawa Y
and Sakamoto M: Upregulated SMAD3 promotes epithelial-mesenchymal
transition and predicts poor prognosis in pancreatic ductal
adenocarcinoma. Lab Invest. 94:683–691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Masugi Y, Yamazaki K, Emoto K, Effendi K,
Tsujikawa H, Kitago M, Itano O, Kitagawa Y and Sakamoto M:
Upregulation of integrin β4 promotes epithelial-mesenchymal
transition and is a novel prognostic marker in pancreatic ductal
adenocarcinoma. Lab Invest. 95:308–319. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xia S, Feng Z, Qi X, Yin Y, Jin J, Wu Y,
Wu H, Feng Y and Tao M: Clinical implication of Sox9 and activated
Akt expression in pancreatic ductal adenocarcinoma. Med Oncol.
32:3582015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mizuuchi Y, Aishima S, Ohuchida K, Shindo
K, Fujino M, Hattori M, Miyazaki T, Mizumoto K, Tanaka M and Oda Y:
Anterior gradient 2 downregulation in a subset of pancreatic ductal
adenocarcinoma is a prognostic factor indicative of
epithelial-mesenchymal transition. Lab Invest. 95:193–206. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Glazer ES, Welsh E, Pimiento JM, Teer JK
and Malafa MP: TGFβ1 overexpression is associated with improved
survival and low tumor cell proliferation in patients with
early-stage pancreatic ductal adenocarcinoma. Oncotarget.
8:999–1006. 2017.PubMed/NCBI
|
|
13
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Smyth GK: Limma: Linear Models for
Microarray Data. Springer; New York: 2005
|
|
15
|
Wang X, Kang DD, Shen K, Song C, Lu S,
Chang LC, Liao SG, Huo Z, Tang S, Ding Y, et al: An R package suite
for microarray meta-analysis in quality control, differentially
expressed gene analysis and pathway enrichment detection.
Bioinformatics. 28:2534–2536. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Porcher R: CORR insights (®):
Kaplan-meier survival analysis overestimates the risk of revision
arthroplasty: A meta-analysis. Clin Orthop Relat Res.
473:3443–3445. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nowicka-Zagrajek J and Weron R: COR:
MATLAB function to compute the correlation coefficients. Hsc
Software. 2008.
|
|
18
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reimand J, Tooming L, Peterson H, Adler P
and Vilo J: GraphWeb: Mining heterogeneous biological networks for
gene modules with functional significance. Nucleic Acids Res.
36:W452–W459. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dimitriadou E, Hornik K, Leisch F and
Meyer D: The e1071 package. Ethnos J Anthropol. 23:55–56. 2006.
|
|
21
|
Smith B, Williams J and Schulze-Kremer S:
The ontology of the gene ontology. AMIA Annu Symp Proc. 609–613.
2003.PubMed/NCBI
|
|
22
|
Aoki KF and Kanehisa M: Using the KEGG
database resource. Curr Protoc Bioinformatics. Chapter.
1:Unit1.122012.
|
|
23
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sahin F, Maitra A, Argani P, Sato N,
Maehara N, Montgomery E, Goggins M, Hruban RH and Su GH: Loss of
Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod
Pathol. 16:686–691. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hezel AF and Bardeesy N: LKB1; linking
cell structure and tumor suppression. Oncogene. 27:6908–6919. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato N, Rosty C, Jansen M, Fukushima N,
Ueki T, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH and
Goggins M: STK11/LKB1 Peutz-Jeghers gene inactivation in
intraductal papillary-mucinous neoplasms of the pancreas. Am J
Pathol. 159:2017–2022. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Morton JP, Jamieson NB, Karim SA, Athineos
D, Ridgway RA, Nixon C, McKay CJ, Carter R, Brunton VG, Frame MC,
et al: LKB1 haploinsufficiency cooperates with kras to promote
pancreatic cancer through suppression of p21-dependent growth
arrest. Gastroenterology. 139(586–597): e1–6. 2010.
|
|
28
|
Wei C, Amos CI, Stephens LC, Campos I,
Deng JM, Behringer RR, Rashid A and Frazier ML: Mutation of Lkb1
and p53 genes exert a cooperative effect on tumorigenesis. Cancer
Res. 65:11297–11303. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qanungo S, Haldar S and Basu A:
Restoration of silenced peutz-jeghers syndrome gene, LKB1, induces
apoptosis in pancreatic carcinoma cells. Neoplasia. 5:367–374.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okada K, Hirabayashi K, Imaizumi T,
Matsuyama M, Yazawa N, Dowaki S, Tobita K, Ohtani Y, Tanaka M,
Inokuchi S and Makuuchi H: Stromal thrombospondin-1 expression is a
prognostic indicator and a new marker of invasiveness in
intraductal papillary-mucinous neoplasm of the pancreas. Biomed
Res. 31:13–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bocci G, Fioravanti A, Orlandi P, Di
Desidero T, Natale G, Fanelli G, Viacava P, Naccarato AG, Francia G
and Danesi R: Metronomic ceramide analogs inhibit angiogenesis in
pancreatic cancer through up-regulation of caveolin-1 and
thrombospondin-1 and down-regulation of cyclin D1. Neoplasia.
14:833–845. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tobita K, Kijima H, Dowaki S, Oida Y,
Kashiwagi H, Ishii M, Sugio Y, Sekka T, Ohtani Y, Tanaka M, et al:
Thrombospondin-1 expression as a prognostic predictor of pancreatic
ductal carcinoma. Int J Oncol. 21:1189–1195. 2002.PubMed/NCBI
|
|
33
|
Qian X, Rothman VL, Nicosia RF and
Tuszynski GP: Expression of thrombospondin-1 in human pancreatic
adenocarcinomas: Role in matrix metalloproteinase-9 production.
Pathol Oncol Res. 7:251–259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McElroy MK, Kaushal S, Tran Cao HS, Moossa
AR, Talamini MA, Hoffman RM and Bouvet M: Upregulation of
thrombospondin-1 and angiogenesis in an aggressive human pancreatic
cancer cell line selected for high metastasis. Mol Cancer Ther.
8:1779–1786. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kusumawidjaja G, Kayed H, Giese N, Bauer
A, Erkan M, Giese T, Hoheise JD, Friess H and Kleeff J: Basic
transcription factor 3 (BTF3) regulates transcription of
tumor-associated genes in pancreatic cancer cells. Cancer Biol
Ther. 6:367–676. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sahin F, Qiu W, Wilentz RE,
Iacobuziodonahue CA, Grosmark A and Su GH: RPL38, FOSL1 and UPP1
are predominantly expressed in the pancreatic ductal epithelium.
Pancreas. 30:158–167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding WQ, Cheng ZJ, McElhiney J, Kuntz SM
and Miller LJ: Silencing of secretin receptor function by
dimerization with a misspliced variant secretin receptor in ductal
pancreatic adenocarcinoma. Cancer Res. 62:5223–5229.
2002.PubMed/NCBI
|
|
38
|
Körner M, Hayes GM, Rehmann R, Zimmermann
A, Friess H, Miller LJ and Reubi JC: Secretin receptors in normal
and diseased human pancreas: Marked reduction of receptor binding
in ductal neoplasia. Am J Pathol. 167:959–968. 2005. View Article : Google Scholar : PubMed/NCBI
|
